Nelonicline is primarily researched for its potential therapeutic applications, particularly in the field of neuroscience and mental health. It acts as a selective agonist for nicotinic acetylcholine receptors, which play a crucial role in cognitive functions, memory, and attention. This makes it a promising candidate for treating cognitive impairments associated with conditions such as Alzheimer's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). Additionally, its interaction with these receptors suggests potential benefits in managing nicotine addiction, as it may help reduce cravings and withdrawal symptoms. Ongoing studies are exploring its efficacy and safety in these areas, aiming to develop novel treatments for neurological and psychiatric disorders.